glp-1 period cramps Your guide to side effects GLP-1s Offer More Than Weight

Chargo NJ et al

But there are situations where you should absolutely get evaluated instead of simply waiting it out

doi: 10.1016/S0149-2918(03)90089-0

DOI: 10.5772/60632 161

John Buse, Director of the Diabetes Care Center at the University of North Carolina and a principal investigator in GLP-1 outcomes trials, has noted in published commentary that "the antioxidant milieu in type 2 diabetes is genuinely impaired, but whether exogenous supplementation corrects the underlying defect or simply raises circulating levels without tissue impact remains unresolved." [9] That distinction shapes the practical advice: correcting a documented deficiency (measured low whole-blood glutathione in a patient with poorly controlled diabetes) is a different clinical decision from empirically adding glutathione to a well-controlled patient already benefiting from dulaglutide's own oxidative-stress effects